Chapter 6.1.2. Diffuse Lung Disease
Evidence-based Approach to Treatment of Sarcoidosis
- Peter G. Gibson1,
- Michael Abramson2,
- Richard Wood-Baker3,
- Jimmy Volmink4,
- Michael Hensley5,
- Ulrich Costabel6
Published Online: 25 OCT 2007
DOI: 10.1002/9780470987377.ch37
Copyright © 2005 by Blackwell Publishing Ltd
Book Title

Evidence-based Respiratory Medicine
Additional Information
How to Cite
Baughman, R. P. and Selroos, O. (2007) Diffuse Lung Disease, in Evidence-based Respiratory Medicine (eds P. G. Gibson, M. Abramson, R. Wood-Baker, J. Volmink, M. Hensley and U. Costabel), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987377.ch37
Editor Information
- 1
John Hunter Hospital, Newcastle, New South Wales, Australia
- 2
Monash University, Central & Eastern Clinical School, The Alfred, Melbourne, Victoria, Australia
- 3
University of Tasmania, Hobart, Tasmania, Australia
- 4
University of Cape Town, Cape Town, South Africa
- 5
University of Newcastle, Newcastle, New South Wales, Australia
- 6
Ruhrlandklinik, Essen, Germany
Publication History
- Published Online: 25 OCT 2007
- Published Print: 22 NOV 2005
ISBN Information
Print ISBN: 9780727916051
Online ISBN: 9780470987377
- Summary
- Chapter
- References
Keywords:
- sarcoidosis;
- corticosteroid therapy;
- pulmonary sarcoidosis;
- oral corticosteroids;
- inhaled corticosteroids
Summary
This chapter contains sections titled:
Level of evidence to support a recommendation
Corticosteroid therapy
Pulmonary sarcoidosis
Chronic pulmonary sarcoidosis on treatment with systemic corticosteroids
Extrapulmonary sarcoidosis
Alternatives to corticosteroids
Specific agents
